PSI-7977-13C-d3
- Product Name
- PSI-7977-13C-d3
- CAS No.
- 2070009-25-3
- Chemical Name
- PSI-7977-13C-d3
- Synonyms
- PSI-7977-13C-d3;13C,D3-Sofosbuvir;[13C,2H3]-Sofosbuvir;L-Alanine, N-[[P(S),2′R]-2′-deoxy-2′-fluoro-2′-(methyl-13C-d3)-P-phenyl-5′-uridylyl]-, 1-methylethyl ester;isopropyl((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-(methyl-13C-d3)tetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate;Sofosbuvir 13CD3Q: What is Sofosbuvir 13CD3 Q: What is the CAS Number of Sofosbuvir 13CD3 Q: What is the storage condition of Sofosbuvir 13CD3 Q: What are the applications of Sofosbuvir 13CD3
- CBNumber
- CB64666758
- Molecular Formula
- C22H26D3FN3O9P
- Formula Weight
- 533.46
- MOL File
- 2070009-25-3.mol
PSI-7977-13C-d3 Property
- Density
- 1.413±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
- storage temp.
- Store at -20°C
- solubility
- DMF: 20 mg/ml,DMSO: 20 mg/ml,Ethanol: 25 mg/ml,PBS (pH 7.2): 0.2 mg/ml
- form
- A solid
N-Bromosuccinimide Price
- Product number
- 25045
- Product name
- PSI-7977-13C-d3
- Purity
- ≥99% deuterated forms (d1-d3)
- Packaging
- 1mg
- Price
- $456
- Updated
- 2024/03/01
- Product number
- P839642
- Product name
- PSI-7977-13CD3
- Packaging
- 1mg
- Price
- $220
- Updated
- 2021/12/16
- Product number
- 463192
- Product name
- PSI-7977-13CD3
- Packaging
- 1mg
- Price
- $531
- Updated
- 2021/12/16
- Product number
- 52859
- Product name
- PSI-7977-13CD3
- Packaging
- 1mg
- Price
- $700
- Updated
- 2021/12/16
- Product number
- 52859
- Product name
- PSI-7977-13CD3
- Packaging
- 10mg
- Price
- $2600
- Updated
- 2021/12/16
PSI-7977-13C-d3 Chemical Properties,Usage,Production
Description
PSI-7977-13C-d3 is intended for use as an internal standard for the quantification of PSI-7977 by GC- or LC-MS. PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM). PSI-7977 is effective in vitro and in vivo.
Uses
PSI-7977-13CD3 is the isotope labelled analog of PSI-7977. PSI-7977 is a prodrug that is metabolized to the active antiviral agent 2''-deoxy-2''-α-fluoro-β-C-methyluridine-5''-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase.
References
[1] EISUKE MURAKAMI. Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977.[J]. The Journal of Biological Chemistry, 2010, 285 45: 34337-34347. DOI: 10.1074/jbc.m110.161802
[2] MICHAEL J. SOFIA*. Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus[J]. Journal of Medicinal Chemistry, 2010, 53 19: 7202-7218. DOI: 10.1021/jm100863x
[3] ANGELA M LAM. Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus.[J]. Antimicrobial Agents and Chemotherapy, 2012, 56 6: 3359-3368. DOI: 10.1128/aac.00054-12
[4] EDWARD J GANE. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.[J]. The New England Journal of Medicine, 2013: 34-44. DOI: 10.1056/nejmoa1208953
[5] ERIC LAWITZ. Sofosbuvir for previously untreated chronic hepatitis C infection.[J]. New England Journal of Medicine, 2013, 368 20: 1878-1887. DOI: 10.1056/nejmoa1214853
PSI-7977-13C-d3 Preparation Products And Raw materials
Raw materials
Preparation Products
PSI-7977-13C-d3 Suppliers
- Tel
- --
- Fax
- --
- sales@advtechind.com
- Country
- United States
- ProdList
- 6075
- Advantage
- 58
- Tel
- --
- Fax
- --
- cayman@caymanchem.com
- Country
- United States
- ProdList
- 6213
- Advantage
- 81
- Tel
- --
- Fax
- --
- chemicals@usbio.net
- Country
- United States
- ProdList
- 6214
- Advantage
- 80
- Tel
- --
- Fax
- --
- sales@medchemexpress.com
- Country
- United States
- ProdList
- 6398
- Advantage
- 58
- Tel
- --
- Fax
- --
- info@medicalisotopes.com
- Country
- United States
- ProdList
- 3180
- Advantage
- 58